These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8266002)

  • 1. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.
    Madsen BK; Husum D; Videbaek R; Stokholm KH; Saelsen L; Christensen NJ
    Scand J Clin Lab Invest; 1993 Oct; 53(6):569-76. PubMed ID: 8266002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B; Lindvall K; Lundberg JM; Sigurdsson A; Swedberg K
    Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of plasma neuropeptide Y levels in congestive heart failure.
    Maisel AS; Scott NA; Motulsky HJ; Michel MC; Boublik JH; Rivier JE; Ziegler M; Allen RS; Brown MR
    Am J Med; 1989 Jan; 86(1):43-8. PubMed ID: 2910096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of plasma neuropeptide Y levels in patients with congestive heart failure].
    Liu JJ; Shi SG; Han QD
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):687-9. PubMed ID: 7712919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular function and activity of vasoconstrictor systems in patients with chronic heart insufficiency].
    Manthey J; Dietz R; Hackenthal E; Leinberger H; Röhrig N; Schmidt-Gayk H; Schömig A; Schwarz F; Kübler W
    Z Kardiol; 1984 Apr; 73(4):279-88. PubMed ID: 6375188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-induced increases in oxidized low-density lipoprotein are associated with adverse outcomes in chronic heart failure.
    Jorde UP; Colombo PC; Ahuja K; Hudaihed A; Onat D; Diaz T; Hirsh DS; Fisher EA; Tseng CH; Vittorio TJ
    J Card Fail; 2007 Nov; 13(9):759-64. PubMed ID: 17996825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma levels of basal beta-endorphin and after effort in patients with severe left ventricular dysfunction and heart failure].
    Perna GP; Modoni S; Valle G; Stanislao M; de Luca G; Fanelli R; Loperfido F
    G Ital Cardiol; 1994 Sep; 24(9):1077-85. PubMed ID: 7995489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure.
    Feng Q; Lambert ML; Callow ID; Arnold JM
    Clin Pharmacol Ther; 2000 Mar; 67(3):292-8. PubMed ID: 10741633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes of exercise-induced plasma catecholamines and neuropeptide Y responses in normal human subjects.
    Winther Jensen E; Espersen K; Kanstrup IL; Christensen NJ
    Acta Physiol Scand; 1992 Feb; 144(2):129-33. PubMed ID: 1575046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma catecholamines and hemodynamics in left heart failure (author's transl)].
    Lehmann M; Keul J; Löllgen H; Just H
    Z Kardiol; 1981 Apr; 70(4):238-44. PubMed ID: 7234055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of free and conjugated plasma catecholamines as indicators of left ventricular contraction disorder of the heart].
    Lehmann M; Schmid P; Spöri U; Keul J
    Z Kardiol; 1983 Sep; 72(9):523-8. PubMed ID: 6685411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen uptake kinetics during exercise in chronic heart failure: influence of peripheral vascular reserve.
    Hepple RT; Liu PP; Plyley MJ; Goodman JM
    Clin Sci (Lond); 1999 Nov; 97(5):569-77. PubMed ID: 10545307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.
    Borlaug BA; Melenovsky V; Russell SD; Kessler K; Pacak K; Becker LC; Kass DA
    Circulation; 2006 Nov; 114(20):2138-47. PubMed ID: 17088459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Level of neuropeptide Y in serum of patients with chronic congestive heart failure].
    Halawa B
    Pol Arch Med Wewn; 1996 May; 95(5):427-32. PubMed ID: 8848410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.
    Olson LJ; Snyder EM; Beck KC; Johnson BD
    J Card Fail; 2006 May; 12(4):299-306. PubMed ID: 16679264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failure.
    Peng Y; Shan J; Qi X; Xue H; Rong C; Yao D; Guo Z; Zheng S
    Chin Med J (Engl); 2003 Oct; 116(10):1459-63. PubMed ID: 14570600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
    Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
    Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.